AS
Insider
Alan Sebulsky
DirectorAlan Sebulsky (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Parabilis Medicines, Inc. (PBLS). Across 2 priced purchase filings, the average 21-session return was +1.5% from execution and +13.3% from disclosure (delay-adjusted; derived). The largest single filing was $474K of PBLS (17,500 sh across 3 lots, as filed), executed Jun 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+1.5%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+13.3%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$724K
shares × price, as filed
Last traded
Jun 15
Filed Jun 16
Median ADV $27.9M across their filed names
Open performance→Volume by month
Buys $724K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
PBLSRecent filings
PBLSPURCHASE
Parabilis Medicines, Inc.
View filing →
$474K17,500 sh across 3 lots
Exec Jun 12
Filed Jun 16 · 6:19 PM ET PBLSPURCHASE Parabilis Medicines, Inc. View filing → $250K
12,500 sh × $20.00
Exec Jun 11
Filed Jun 15 · 5:27 PM ET